BARBIE JOHNSON: Open Payments
NPI 1396280137 · NEWBERRY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,159 in 66 payments from 21 companies in 2025. Trend: 2023 $605 · 2024 $485 · 2025 $1,159
Food & beverage: $1,159
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 5 | $197 |
| ABBVIE INC. | 16 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $137 |
| Novo Nordisk Inc | 5 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| PFIZER INC. | 3 | $59 |
| Amgen Inc. | 3 | $52 |
| Phathom Pharmaceuticals, Inc. | 3 | $50 |
| Lundbeck LLC | 2 | $47 |
| Lilly USA, LLC | 2 | $42 |
Products named: Korlym, VRAYLAR, CAPLYTA, JARDIANCE, REXULTI, NURTEC ODT, Ozempic, VOQUEZNA.
Industry payments across SC — which companies pay providers there.
